“…To investigate the reason, the dose and frequency of oTA or with RTA agents were 500 mg/day, 16,17,31,36,37,54,55,57,63,64 while the frequency of iTA and MNsTA was basically once every 2 or 4 weeks, and the concentration of liquid medicine was 4 mg/mL. [16][17][18]27,33,36,39,40,47,48,51 Therefore, oTA with high-frequency and concentration had a faster effect than iTA and MNsTA. In these studies, oTA or with RTA agents produced an early response and cleared melasma at Week 4, and tTA, iTA and MNsTA responded slowly in the first 4 weeks with only mild improvement or no response, while the improvement continued, with a moderate to good response in most patients at Week 8.…”